Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for MASI
+1.37 (1.57%)
Feb 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 86.69 - 88.63
52 week 37.16 - 88.63
Open 86.79
Vol / Avg. 764,517.00/642,034.00
Mkt cap 4.53B
P/E 15.85
Div/yield     -
EPS 5.59
Shares 50.42M
Beta 0.97
Inst. own 84%
Feb 21, 2017
Q4 2016 Masimo Corp Earnings Release (Estimated)
Nov 29, 2016
Masimo Corp at Piper Jaffray Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 117.52% 43.28%
Operating margin 169.43% 60.58%
EBITD margin - 24.13%
Return on average assets 118.29% 42.28%
Return on average equity 193.31% 71.96%
Employees 1,243 -
CDP Score - -


52 Discovery
IRVINE, CA 92618-3105
United States - Map
+1-949-2977000 (Phone)
+1-949-2977499 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.

Officers and directors

Joseph E. Kiani Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President - Finance
Age: 56
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 52
Bio & Compensation  - Reuters
Rick Fishel President, Worldwide OEM Business & Blood Management
Age: 58
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President, Chief Information Officer
Age: 51
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Business Development
Age: 45
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 71
Bio & Compensation  - Reuters
Adam P. Mikkelson Director
Age: 38
Bio & Compensation  - Reuters